The Crisis

Nine out of ten of the biggest drug makers spent 50% more on advertising their products than researching and developing new ones.

Nine out of ten of the biggest drug makers spent 50% more on advertising their products than researching and developing new ones.

PRESCRIPTION DRUG PRICES ON THE RISE

Drug prices are out-of-control. While Big Pharma is posting record profits, too many hardworking Americans are having to choose between paying their bills and accessing life-saving medicines. Enough is enough.
Yes, pharmaceutical companies make life-saving treatments and breakthrough cures. But it does not give them the right to price gouge sick Americans by drastically increasing prices and blocking affordable generic competition.
It’s simple: no patient should ever have to choose between paying for their daily needs or taking the medicine they need to live.

QUICK FACTS

The unsustainable cost of prescription drugs not only puts pressure on the health care system but increasingly; patients, employers, and providers are paying prices that are too high.

THE CONSEQUENCES OF HIGHER COSTS

When Big Pharma is able to prevent competition and maintain a monopoly on medicines, they can set any price they want. That's how they've been able to raise the price of insulin by more than 200 percent over the past decade and prevent any generic competition for more than 90 years. The simple truth is patients end up paying more – regardless of what kind of insurance coverage they have. That's called price gouging.

AFFORDABLE SOLUTIONS

Americans deserve choice and control over their health. We must all work together to promote competition and increase access to high-quality, affordable treatments and cures for patients. CSRxP has outlined real solutions that can deliver more choices, more competition, and lower costs.

Summary of CSRxP Market-Based Solutions

Summary of CSRxP Market-Based Solutions

Detailed CSRxP Market-Based Solutions

Detailed CSRxP Market-Based Solutions

THE BOTTOM LINE

It's time to take politics out of health care. Every person deserves access to the medications they need at a price they can afford, especially those who can least afford them. We should not have to choose between innovation and affordability. With the right solutions and genuine collaboration, we can have both.